IO Biotech | 8-K: Current report
Apr 26 17:29 ET
IO Biotech | DEF 14A: Definitive information statements
Apr 24 16:11 ET
IO Biotech | ARS: Annual Report to Security Holders
Apr 24 16:10 ET
IO Biotech | DEFA14A: Others
Apr 24 16:09 ET
IO Biotech | 10-K/A: Annual report (Amendment)
Mar 22 17:08 ET
IO Biotech | 4: Statement of changes in beneficial ownership of securities-Officer Zocca Mai-Britt
Mar 18 16:32 ET
IO Biotech | 4: Statement of changes in beneficial ownership of securities-Officer Smith Devin Whittemore
Mar 18 16:27 ET
IO Biotech | 4: Statement of changes in beneficial ownership of securities-Officer Sullivan Amy
Mar 18 16:26 ET
IO Biotech | 4: Statement of changes in beneficial ownership of securities-Officer Burkavage Brian
Mar 18 16:26 ET
IO Biotech | 4: Statement of changes in beneficial ownership of securities-Officer Ahmad Qasim Iftikhar
Mar 18 16:22 ET
IO Biotech | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 11 16:58 ET
IO Biotech | 10-K: Annual report
Mar 5 17:23 ET
IO Biotech | 8-K: IO Biotech Announces 2023 Fourth-Quarter and Year-End Results
Mar 5 16:53 ET
IO Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avoro Capital Advisors LLC(0%),Behzad Aghazadeh(0%)
Feb 14 09:03 ET
IO Biotech | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novo Holdings A/S(11.1%)
Feb 13 21:36 ET
IO Biotech | 4: Statement of changes in beneficial ownership of securities-10% Owner Novo Holdings A/S
Feb 13 21:36 ET
IO Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BANK OF AMERICA CORPORATION(2.8%)
Feb 13 19:41 ET
IO Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-HBM Healthcare Investments (Cayman) Ltd.(6.0%)
Feb 13 16:49 ET
IO Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Feb 13 16:35 ET
IO Biotech | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 9 21:35 ET
No Data
No Data